IDEXX Laboratories, Inc. logo
IDEXX Laboratories, Inc. (IDXX)
Compare

IDEXX Laboratories, Inc. (IDXX) EV/EBITDA Ratio: 30.48x

Is IDEXX Laboratories, Inc.’s EV/EBITDA ratio high or low?

IDEXX Laboratories, Inc.'s EV/EBITDA ratio of 30.48x is 20% below its 5-year average of 38.26x, near the low end of its 5-year range (23.90x–68.80x).

The EV/EBITDA ratio for IDEXX Laboratories, Inc. (IDXX) is 30.48x as of Wednesday, June 10, 2026. It is below its 12-month average by 14.74% (35.75x).

IDXX EV/EBITDA Ratio Chart

IDXX EV/EBITDA Ratio
30.48x-10.38% 1Y
Zoom

IDXX Average EV/EBITDA Ratio Chart

IDXX Current vs Average EV/EBITDA Ratio Chart

IDXX EV/EBITDA Ratio Metrics

EV/EBITDA RATIO

30.48x

EV/EBITDA RATIO AVG TTM

35.75x

EV/EBITDA RATIO AVG 3Y

34.46x

EV/EBITDA RATIO AVG 5Y

38.26x

EV/EBITDA RATIO AVG 10Y

38.52x

EV/EBITDA RATIO AVG 15Y

32.14x

EV/EBITDA RATIO AVG 20Y

28.65x

CURRENT VS TTM AVG

-14.74%

CURRENT VS 3Y AVG

-11.55%

CURRENT VS 5Y AVG

-20.33%

CURRENT VS 10Y AVG

-20.88%

CURRENT VS 15Y AVG

-5.15%

CURRENT VS 20Y AVG

+6.39%

IDXX Competitors' EV/EBITDA Ratio

NAMEMARKET CAPEV/EBITDA RATIOTTM3Y5Y
IDEXX Laboratories, Inc. (IDXX)$44.47B30.48x35.75x34.46x38.26x
Humana Inc. (HUM)$43.78B18.61x11.68x11.33x12.36x
Agilent Technologies, Inc. (A)$37.17B20.92x21.12x21.69x23.11x
Zoetis Inc. (ZTS)$34.20B10.33x15.67x20.68x23.76x
Centene Corporation (CNC)$31.94BN/A4.99x7.28x9.49x
Medline Inc. (MDLN)$30.90B13.75x15.00x15.00x15.00x
IQVIA Holdings Inc. (IQV)$30.60B8.90x13.19x14.98x17.09x
DexCom, Inc. (DXCM)$29.24B23.24x28.10x43.48x70.03x
Biogen Inc. (BIIB)$29.00B11.60x8.56x11.16x12.22x
Veeva Systems Inc. (VEEV)$26.73B25.37x43.29x56.90x62.37x

EV/EBITDA vs. its own history

At 30.5, EV/EBITDA is in its normal range — richer than 57% of its 20-year range.

20-year low

6.1

median

27.4

20-year high

68.8

cheaperricher

Understanding EV/EBITDA

Enterprise Value (EV) = Market Cap + Total Debt - Cash

EBITDA = Earnings Before Interest, Taxes, Depreciation & Amortization

EV/EBITDA is commonly used for comparing companies because:

  • It accounts for debt levels (capital structure neutral)
  • It removes effects of different depreciation policies
  • It can be compared across countries with different tax rates
  • It can remain available when net income is negative, if EBITDA is positive

IDEXX Laboratories, Inc. EV/EBITDA Ratio Formula & Definition

EV/EBITDA = Enterprise Value / EBITDA (TTM)

Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

IDEXX Laboratories, Inc. EV/EBITDA Ratio FAQ

What is the EV/EBITDA ratio for IDEXX Laboratories, Inc. (IDXX)?
The EV/EBITDA ratio for IDXX stock is 30.48x.
Is IDEXX Laboratories, Inc.'s EV/EBITDA ratio high or low?
IDEXX Laboratories, Inc.'s EV/EBITDA ratio of 30.48x is 20% below its 5-year average of 38.26x, near the low end of its 5-year range (23.90x–68.80x).
What is the TTM average EV/EBITDA ratio for IDEXX Laboratories, Inc. (IDXX)?
The TTM average EV/EBITDA ratio for IDXX stock is 35.75x.
What is the 3Y average EV/EBITDA ratio for IDEXX Laboratories, Inc. (IDXX)?
The 3Y average EV/EBITDA ratio for IDXX stock is 34.46x.
What is the 5Y average EV/EBITDA ratio for IDEXX Laboratories, Inc. (IDXX)?
The 5Y average EV/EBITDA ratio for IDXX stock is 38.26x.
What is the 10Y average EV/EBITDA ratio for IDEXX Laboratories, Inc. (IDXX)?
The 10Y average EV/EBITDA ratio for IDXX stock is 38.52x.
What is the 15Y average EV/EBITDA ratio for IDEXX Laboratories, Inc. (IDXX)?
The 15Y average EV/EBITDA ratio for IDXX stock is 32.14x.
What is the 20Y average EV/EBITDA ratio for IDEXX Laboratories, Inc. (IDXX)?
The 20Y average EV/EBITDA ratio for IDXX stock is 28.65x.

IDEXX Laboratories, Inc. EV/EBITDA Ratio History

DATEEV/EBITDA RATIO
2026-06-1030.48x
2026-06-0931.30x
2026-06-0830.36x
2026-06-0530.41x
2026-06-0430.55x
2026-06-0330.33x
2026-06-0229.81x
2026-06-0130.65x
2026-05-2930.48x
2026-05-2830.72x
2026-05-2729.82x
2026-05-2630.15x
2026-05-2230.26x
2026-05-2129.93x
2026-05-2029.95x
2026-05-1929.58x
2026-05-1829.54x
2026-05-1528.64x
2026-05-1428.85x
2026-05-1328.63x
2026-05-1228.91x
2026-05-1128.81x
2026-05-0830.30x
2026-05-0730.94x
2026-05-0631.31x
2026-05-0530.45x
2026-05-0430.69x
2026-05-0130.92x
2026-04-3030.57x
2026-04-2930.18x
2026-04-2830.97x
2026-04-2731.32x
2026-04-2430.84x
2026-04-2330.57x
2026-04-2231.50x
2026-04-2131.00x
2026-04-2031.76x
2026-04-1732.09x
2026-04-1631.05x
2026-04-1531.63x
2026-04-1431.81x
2026-04-1331.27x
2026-04-1030.68x
2026-04-0931.85x
2026-04-0832.22x
2026-04-0731.31x
2026-04-0631.45x
2026-04-0231.03x
2026-04-0130.77x
2026-03-3130.62x
2026-03-3030.37x
2026-03-2730.43x
2026-03-2631.23x
2026-03-2531.36x
2026-03-2431.07x
2026-03-2331.51x
2026-03-2031.45x
2026-03-1931.58x
2026-03-1831.44x
2026-03-1731.96x
2026-03-1631.93x
2026-03-1331.26x
2026-03-1231.12x
2026-03-1132.69x
2026-03-1032.60x
2026-03-0933.22x
2026-03-0633.11x
2026-03-0533.67x
2026-03-0435.26x
2026-03-0334.56x
2026-03-0234.62x
2026-02-2735.69x
2026-02-2635.91x
2026-02-2535.73x
2026-02-2435.29x
2026-02-2333.90x
2026-02-2034.57x
2026-02-1935.67x
2026-02-1835.90x
2026-02-1735.42x
2026-02-1335.59x
2026-02-1234.92x
2026-02-1136.67x
2026-02-1036.55x
2026-02-0936.17x
2026-02-0636.44x
2026-02-0536.38x
2026-02-0436.35x
2026-02-0335.77x
2026-02-0236.16x
2026-01-3037.88x
2026-01-2938.23x
2026-01-2838.84x
2026-01-2739.23x
2026-01-2639.40x
2026-01-2339.18x
2026-01-2239.02x
2026-01-2139.32x
2026-01-2038.74x
2026-01-1640.37x
2026-01-1540.19x
2026-01-1440.10x
2026-01-1340.30x
2026-01-1240.90x
2026-01-0940.26x
2026-01-0840.21x
2026-01-0740.33x
2026-01-0639.90x
2026-01-0538.53x
2026-01-0237.85x
2025-12-3138.22x
2025-12-3038.54x
2025-12-2938.85x
2025-12-2638.88x
2025-12-2438.86x
2025-12-2338.54x
2025-12-2239.64x
2025-12-1939.54x
2025-12-1839.36x
2025-12-1739.27x
2025-12-1639.14x
2025-12-1539.55x
2025-12-1239.75x
2025-12-1139.94x
2025-12-1039.62x
2025-12-0939.47x
2025-12-0839.89x
2025-12-0540.30x
2025-12-0440.49x
2025-12-0340.96x
2025-12-0241.34x
2025-12-0141.13x
2025-11-2842.46x
2025-11-2642.63x
2025-11-2543.22x
2025-11-2442.42x
2025-11-2140.96x
2025-11-2038.93x
2025-11-1939.36x
2025-11-1837.86x
2025-11-1737.80x
2025-11-1438.96x
2025-11-1339.60x
2025-11-1240.27x
2025-11-1140.21x
2025-11-1040.05x
2025-11-0739.99x
2025-11-0640.28x
2025-11-0540.64x
2025-11-0440.75x
2025-11-0340.79x
2025-10-3137.14x
2025-10-3037.08x
2025-10-2937.03x
2025-10-2837.42x
2025-10-2738.17x
2025-10-2437.79x
2025-10-2337.66x
2025-10-2237.38x
2025-10-2137.58x
2025-10-2037.94x
2025-10-1737.48x
2025-10-1637.59x
2025-10-1537.69x
2025-10-1437.56x
2025-10-1337.36x
2025-10-1036.36x
2025-10-0937.09x
2025-10-0837.16x
2025-10-0737.01x
2025-10-0637.04x
2025-10-0337.23x
2025-10-0237.39x
2025-10-0136.59x
2025-09-3037.68x
2025-09-2937.20x
2025-09-2637.29x
2025-09-2536.48x
2025-09-2437.00x
2025-09-2338.23x
2025-09-2237.98x
2025-09-1938.68x
2025-09-1838.64x
2025-09-1737.79x
2025-09-1638.07x
2025-09-1537.97x
2025-09-1237.81x
2025-09-1138.04x
2025-09-1037.62x
2025-09-0938.64x
2025-09-0838.48x
2025-09-0537.92x
2025-09-0437.77x
2025-09-0337.39x
2025-09-0237.71x
2025-08-2938.15x
2025-08-2838.15x
2025-08-2737.79x
2025-08-2637.84x
2025-08-2537.82x
2025-08-2238.06x
2025-08-2137.34x
2025-08-2037.73x
2025-08-1937.55x
2025-08-1837.62x
2025-08-1538.37x
2025-08-1438.55x
2025-08-1339.13x
2025-08-1238.45x
2025-08-1138.44x
2025-08-0838.79x
2025-08-0738.32x
2025-08-0636.83x
2025-08-0537.86x
2025-08-0440.21x
2025-08-0134.62x
2025-07-3134.54x
2025-07-3036.94x
2025-07-2937.00x
2025-07-2836.58x
2025-07-2536.50x
2025-07-2435.53x
2025-07-2334.95x
2025-07-2234.40x
2025-07-2133.69x
2025-07-1833.29x
2025-07-1733.55x
2025-07-1633.67x
2025-07-1534.06x
2025-07-1434.36x
2025-07-1134.48x
2025-07-1034.97x
2025-07-0934.94x
2025-07-0834.83x
2025-07-0735.26x
2025-07-0335.35x
2025-07-0235.07x
2025-07-0135.07x
2025-06-3034.67x
2025-06-2734.35x
2025-06-2634.13x
2025-06-2534.29x
2025-06-2434.30x
2025-06-2333.93x
2025-06-2033.88x
2025-06-1833.63x
2025-06-1733.67x
2025-06-1634.19x
2025-06-1333.81x
2025-06-1234.07x
2025-06-1133.90x
2025-06-1034.01x
2025-06-0933.55x
2025-06-0633.95x
2025-06-0533.78x
2025-06-0433.94x
2025-06-0334.01x
2025-06-0233.31x
2025-05-3033.22x
2025-05-2933.35x

Showing the most recent 260 of 5,031 data points. The chart above shows the full history.

About IDEXX Laboratories, Inc.

IDEXX Laboratories, Inc. is a global enterprise focused on creating, producing, and distributing a wide array of products and services. Its primary client base includes companion animal veterinary practices, the livestock and poultry industries, dairy operations, and water quality testing sectors. The company organizes its operations across several key divisions: the Companion Animal Group (CAG), Water Quality Products, Livestock, Poultry, and Dairy (LPD), and additional segments. For companion animals, IDEXX offers a comprehensive suite of point-of-care veterinary diagnostic tools, such as instruments, consumables, and rapid assay kits. It also provides reference laboratory diagnostic and consultation services, alongside practice management and diagnostic imaging solutions for veterinarians. Furthermore, the company supports the biomedical research community with health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services. In the livestock, poultry, and dairy markets, IDEXX supplies diagnostic and health-monitoring solutions. Its water testing portfolio includes products designed to detect various microbiological contaminants, notably the Colilert, Colilert-18, and Colisure tests for total coliforms and E. coli, as well as Enterolert, Pseudalert, Filta-Max, Filta-Max xpress, Legiolert, and Quanti-Tray products. Beyond these, IDEXX extends its reach to human point-of-care medical diagnostics, offering electrolyte and blood gas analyzers, and SARS-CoV-2 RT-PCR tests. Other key offerings encompass in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers, as well as SNAP rapid assay test kits. Veterinary software and services for both independent clinics and large corporate veterinary groups are also part of its offerings. The company distributes its extensive product and service catalog through its own dedicated marketing, customer service, sales, and technical service teams, supplemented by independent distributors and other resellers. IDEXX Laboratories, Inc. was established in 1983 and maintains its headquarters in Westbrook, Maine.

Westbrook, ME
11,000 employees
Healthcare / Medical - Diagnostics & Research
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Jonathan J. Mazelsky